What is the current Pharma Hard Gelatin Capsules market size?

The current market size is approximately USD 1.2 billion as of 2023, driving future outlook.

What is the expected growth forecast for the Pharma Hard Gelatin Capsules market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by key drivers.

What are the key drivers of the Pharma Hard Gelatin Capsules market?

Increasing demand for capsules and rising healthcare expenditures are key drivers of market growth.

What are the major challenges facing the Pharma Hard Gelatin Capsules market?

Stringent regulations and raw material shortages are significant challenges impacting market growth.

Which regions are the leaders in the Pharma Hard Gelatin Capsules market?

North America and Europe are regional leaders, with Asia-Pacific emerging as a growth hub.

Who are the top companies in the Pharma Hard Gelatin Capsules market?

Key players include Capsugel, Qualicaps, and ACG, driving market innovation and competition.

What are the future opportunities in the Pharma Hard Gelatin Capsules market?

Emerging markets and technological advancements offer significant future opportunities for growth.

How is technology impacting the Pharma Hard Gelatin Capsules market?

Advances in capsule manufacturing technology are improving efficiency and product quality.

What is the current regulatory landscape for the Pharma Hard Gelatin Capsules market?

Regulations around capsule quality and safety are evolving, with a focus on compliance and standards.

Pharma Hard Gelatin Capsules - Strategic Insights: Analysis 2025 and Forecasts 2033

Pharma Hard Gelatin Capsules by Application (Pharmaceutical, Healthcare Products, Other), by Types (Stomach-soluble Gelatin Capsules, Enterosoluble Vacant Gelatin Capsules, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Pharma Hard Gelatin Capsules Market Size | CAGR 7.2 Forecast 2033

Pharma Hard Gelatin Capsules - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pharma Hard Gelatin Capsules Market Overview

The Pharma Hard Gelatin Capsules market refers to the global industry involved in the manufacture and supply of hard gelatin capsules used in the pharmaceutical sector. As a crucial component in the pharmaceutical packaging industry, the Pharma Hard Gelatin Capsules market size is estimated to be around $2.5 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $4.3 billion by 2033, driven by an increasing demand for capsules in the pharmaceutical industry. The industry expansion is expected to be fueled by factors such as the growing demand for capsules, advancements in capsule technology, and the rising popularity of capsule-based medications. The global Pharma Hard Gelatin Capsules market is expected to witness a CAGR of 7.5% during the forecast period, driven by macro drivers such as the increasing geriatric population and the rising prevalence of chronic diseases.

Loading chart…

The key forces shaping the Pharma Hard Gelatin Capsules industry include technology shifts, such as the development of new capsule materials and manufacturing processes, regulations, such as the increasing focus on patient safety and compliance with regulatory standards, and consumer behavior, such as the growing demand for convenient and easy-to-swallow medications. The largest region in the Pharma Hard Gelatin Capsules market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing demand for capsules in countries such as China and India. Overall, the Pharma Hard Gelatin Capsules market is expected to witness significant growth during the forecast period, driven by the increasing demand for capsules and the growing popularity of capsule-based medications.

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	8.37 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Lonza; Qualicaps; ACG; Suheung; Farmacapsulas SA; ERAWAT PHARMA LIMITED; Dah Feng Capsule; Lefan Capsule; Shing Lih Fang; Roxlor; Nectar Lifesciences; Kangke; Angtai; Tsingtao Capsule; Huangshan Capsule; MEIHUA Group; Yili Capsule
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pharma Hard Gelatin Capsules market is poised for significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the industry's trajectory.

Growth Drivers2 items

Increasing demand for hard gelatin capsules in the pharmaceutical industry, driven by their versatility and ease of use in various applications, is expected to contribute to the Pharma Hard Gelatin Capsules market size.

Advances in capsule manufacturing technology have improved production efficiency and reduced costs, making hard gelatin capsules a more attractive option for pharmaceutical companies, thereby supporting the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements governing the use of gelatin in pharmaceutical applications may limit the adoption of hard gelatin capsules in certain regions, potentially hindering the growth of the Pharma Hard Gelatin Capsules market.

Fluctuations in raw material prices, such as gelatin, can impact the production costs of hard gelatin capsules, making it challenging for manufacturers to maintain profitability and comply with pricing pressures.

Opportunities2 items

The growing demand for sustained-release formulations and controlled-release medications presents opportunities for manufacturers of hard gelatin capsules to develop innovative products that meet these needs, driving growth in the Pharma Hard Gelatin Capsules market.

The increasing outsourcing of pharmaceutical manufacturing to contract manufacturers in emerging economies creates opportunities for hard gelatin capsule manufacturers to expand their customer base and increase their market share.

Challenges2 items

The Pharma Hard Gelatin Capsules market faces challenges from alternative capsule formats, such as soft gelatin capsules and vegetarian capsules, which may appeal to consumers with specific preferences or dietary requirements.

Ensuring supply chain integrity and quality control is crucial for hard gelatin capsule manufacturers, as any lapses can impact product quality and compromise patient safety, ultimately affecting the growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment in the Pharma Hard Gelatin Capsules market refers to the various uses of these capsules in the pharmaceutical industry. This segment contributes significantly to the overall market size, with applications ranging from prescription drugs to over-the-counter medications. The Pharma Hard Gelatin Capsules segmentation by application is crucial in understanding the market dynamics, as different applications have distinct requirements and demand patterns.

The Types segment in the Pharma Hard Gelatin Capsules market includes subtypes such as [object Object] and [object Object]. This segment is essential in determining the market taxonomy, as different types of capsules have varying characteristics, such as size, shape, and material. The market size of each subtype contributes to the overall Pharma Hard Gelatin Capsules market size, with some subtypes experiencing higher demand than others due to their specific applications and benefits.

Pharma Hard Gelatin Capsules Segmentation Breakdown8 items

Application

Pharmaceutical

Healthcare Products

Other

Types

Stomach-soluble Gelatin Capsules

Enterosoluble Vacant Gelatin Capsules

Other

Regional Insights

Loading chart…

The Pharma Hard Gelatin Capsules market growth is expected to vary across regions, with the largest share attributed to North America, accounting for approximately 35% of the market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of hard gelatin capsules, favorable policies, and significant investments in the pharmaceutical industry.

Key drivers for North America include a mature ecosystem, high infrastructure development, and a large consumer base. In Europe, drivers include strict regulations and a strong focus on research and development. Asia Pacific is driven by growing demographics, increasing healthcare expenditure, and rising demand for pharmaceutical products. Latin America and Middle East & Africa are expected to witness moderate growth, driven by improving infrastructure and increasing foreign investments.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by emerging economies such as China and India. North America and Europe will continue to dominate the market, while Latin America and Middle East & Africa will witness steady growth. The Pharma Hard Gelatin Capsules market is expected to grow significantly, driven by increasing demand for pharmaceutical products and rising adoption of hard gelatin capsules.

Competitive Landscape

The Pharma Hard Gelatin Capsules competitive landscape is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market structure is characterized by high competition, with companies focusing on differentiation through product quality, service model, and channel strength. Understanding the Pharma Hard Gelatin Capsules competitive landscape is crucial for companies to develop effective strategies and stay ahead in the market.

Companies in the market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To overcome these challenges, companies are focusing on strategic initiatives such as regional expansion, vertical integration, and innovation pipeline development. The following companies are examples of this trend:

Lonza: regional expansion

Qualicaps: premium pricing

ACG: OEM tie-ups

Suheung: local manufacturing

Farmacapsulas SA: innovation pipeline

ERAWAT PHARMA LIMITED: vertical integration

Key Pharma Hard Gelatin Capsules Companies17 items

Lonza

Qualicaps

ACG

Suheung

Farmacapsulas SA

ERAWAT PHARMA LIMITED

Dah Feng Capsule

Lefan Capsule

Shing Lih Fang

Roxlor

Nectar Lifesciences

Kangke

Angtai

Tsingtao Capsule

Huangshan Capsule

MEIHUA Group

Yili Capsule

Market Ecosystem

The Pharma Hard Gelatin Capsules ecosystem encompasses a network of participants that interact across the upstream, midstream, and downstream segments, creating and capturing value through the production and delivery of hard gelatin capsules to end users. Technology providers and suppliers of raw materials are the foundation of this ecosystem, providing the necessary components for manufacturers to produce the capsules. These capsules are then distributed to end users through various channels, with system integrators and service providers supporting the process.

Raw material/component suppliers — provide gelatin and other materials

OEMs / manufacturers — produce hard gelatin capsules

Technology providers — develop manufacturing equipment and processes

Distributors / channel partners — deliver capsules to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — pharmaceutical companies and researchers

Regulators/standards bodies — establish quality and safety standards

In the Pharma Hard Gelatin Capsules ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and quality standards. Dependency risks arise from input constraints, such as the availability of raw materials, and standards compliance. Switching costs are relatively high due to the need for compatibility with existing equipment and processes. As part of a thorough value chain analysis, understanding these dynamics is crucial for navigating the ecosystem, particularly as it differs by region due to varying regulatory requirements and market conditions.

Recent Industry Insights

The Pharma Hard Gelatin Capsules industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading pharmaceutical companies and capsule manufacturers, have focused on enhancing production efficiency and quality. Notable mergers and acquisitions have also taken place, with key players expanding their market presence through strategic acquisitions. Furthermore, several companies have launched innovative products and technologies, including sustainably sourced gelatin capsules, to cater to the growing demand for eco-friendly and halal-certified products.

Additionally, regulatory changes, such as updated guidelines for capsule manufacturing, have prompted companies to invest in research and development to ensure compliance. A shift in consumer trends towards vegan and vegetarian capsules has also driven innovation in the industry. Funding rounds and expansions have enabled companies to increase their production capacity and explore new markets, ultimately contributing to the growth of the Pharma Hard Gelatin Capsules market.

Analyst Overview

As the Lead Analyst, I provide an expert view on the Pharma Hard Gelatin Capsules market outlook. The market attractiveness is moderate, driven by growing demand for capsules in the pharmaceutical industry. Competitive intensity is high, with key players competing on quality, pricing, and innovation. The long-term outlook is positive, with opportunities in emerging markets and increasing adoption of capsules in various therapeutic applications.

The innovation landscape is evolving, with advancements in capsule manufacturing technology and the development of new materials. However, the demand-supply balance is a key challenge, with fluctuations in raw material prices and supply chain disruptions. Key risk factors include regulatory changes, quality control issues, and intense competition. Overall, the market requires strategic planning, innovation, and effective risk management to succeed.

11 items

1. Executive Summary

2. Pharma Hard Gelatin Capsules Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pharma Hard Gelatin Capsules Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pharma Hard Gelatin Capsules Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical

6.1.2. Healthcare Products

6.1.3. Other

6.2. Global Pharma Hard Gelatin Capsules Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Stomach-soluble Gelatin Capsules

6.2.2. Enterosoluble Vacant Gelatin Capsules

6.2.3. Other

6.3. Global Pharma Hard Gelatin Capsules Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pharma Hard Gelatin Capsules Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pharma Hard Gelatin Capsules Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pharma Hard Gelatin Capsules Market Competition by Key Manufacturers

8.1. Global Pharma Hard Gelatin Capsules Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pharma Hard Gelatin Capsules: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Lonza

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Qualicaps

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ACG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Suheung

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Farmacapsulas SA

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ERAWAT PHARMA LIMITED

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Dah Feng Capsule

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Lefan Capsule

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shing Lih Fang

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Roxlor

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nectar Lifesciences

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Kangke

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Angtai

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Tsingtao Capsule

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Huangshan Capsule

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. MEIHUA Group

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Yili Capsule

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pharma Hard Gelatin Capsules Market

Figure 4: Global Pharma Hard Gelatin Capsules Market: Drivers

Figure 5: Global Pharma Hard Gelatin Capsules Market: Challenges

Figure 6: Global Pharma Hard Gelatin Capsules Market: Trends

Figure 7: Global Pharma Hard Gelatin Capsules Market: Opportunity

Figure 8: Global Pharma Hard Gelatin Capsules Market: Restraint

Figure 9: Global Pharma Hard Gelatin Capsules Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pharma Hard Gelatin Capsules Market Value (USD Million) By Region

Figure 15: Global Pharma Hard Gelatin Capsules Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pharma Hard Gelatin Capsules Market Value (USD Million) By Region

Figure 23: Global Pharma Hard Gelatin Capsules Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Pharma Hard Gelatin Capsules Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pharma Hard Gelatin Capsules Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pharma Hard Gelatin Capsules Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pharma Hard Gelatin Capsules Market Value (USD Million) By Region

Table 10: Global Pharma Hard Gelatin Capsules Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pharma Hard Gelatin Capsules Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pharma Hard Gelatin Capsules Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pharma Hard Gelatin Capsules Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Lonza Basic Information And Sales Area

Table 31: Lonza. Products Portfolio

Table 32: Qualicaps Basic Information And Sales Area

Table 33: Qualicaps. Products Portfolio

Table 34: ACG Basic Information And Sales Area

Table 35: ACG. Products Portfolio

Table 36: Suheung Basic Information And Sales Area

Table 37: Suheung. Products Portfolio

Table 38: Farmacapsulas SA Basic Information And Sales Area

Table 39: Farmacapsulas SA. Products Portfolio

Table 40: ERAWAT PHARMA LIMITED Basic Information And Sales Area

Table 41: ERAWAT PHARMA LIMITED. Products Portfolio

Table 42: Dah Feng Capsule Basic Information And Sales Area

Table 43: Dah Feng Capsule. Products Portfolio

Table 44: Lefan Capsule Basic Information And Sales Area

Table 45: Lefan Capsule. Products Portfolio

Table 46: Shing Lih Fang Basic Information And Sales Area

Table 47: Shing Lih Fang. Products Portfolio

Table 48: Roxlor Basic Information And Sales Area

Table 49: Roxlor. Products Portfolio

Table 50: Nectar Lifesciences Basic Information And Sales Area

Table 51: Nectar Lifesciences. Products Portfolio

Table 52: Kangke Basic Information And Sales Area

Table 53: Kangke. Products Portfolio

Table 54: Angtai Basic Information And Sales Area

Table 55: Angtai. Products Portfolio

Table 56: Tsingtao Capsule Basic Information And Sales Area

Table 57: Tsingtao Capsule. Products Portfolio

Table 58: Huangshan Capsule Basic Information And Sales Area

Table 59: Huangshan Capsule. Products Portfolio

Table 60: MEIHUA Group Basic Information And Sales Area

Table 61: MEIHUA Group. Products Portfolio

Table 62: Yili Capsule Basic Information And Sales Area

Table 63: Yili Capsule. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Pharma Hard Gelatin Capsules Market Value (USD Million) By Region

Table 69: Global Pharma Hard Gelatin Capsules Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pharma Hard Gelatin Capsules Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	8.37 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Lonza; Qualicaps; ACG; Suheung; Farmacapsulas SA; ERAWAT PHARMA LIMITED; Dah Feng Capsule; Lefan Capsule; Shing Lih Fang; Roxlor; Nectar Lifesciences; Kangke; Angtai; Tsingtao Capsule; Huangshan Capsule; MEIHUA Group; Yili Capsule
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options